药物开发过程:提高效率和成本效益 328条(本栏目收费,不能显示细节,电话13136136841)
In vitro-in vivo correlations, 154-167 167
classification of, 155 155
parameters in, 156-161 161
Iontophoresis, 178, 192 192
clinical needs in, 367-372 372
Ministry of Health and Welfare (MHW), 369 369
preclinical needs in, 362-367 367
quality needs in, 361-362 362
regulatory process in, 354-361 361
Japanese Pharmaceutical Affairs Law (PAL), 354 354
Lactose diluents, 124 124
Liability (see Product liability) Lipid therapy dosage establishment in, 24 24
Makoid-Banakar Function, 139-154 154
practical experiences with, 146-154 154
utility in product development, 145-146 146
Market-Oriented, Sector-Selective (MOSS) talks, 354 354
Metabolic isoforms, 226-229 229
Microcrystalline cellulose, 122 122